Comments

Forte Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Forte Biosciences (FBRX) operate in?

Forte Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

FBRXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$9.67

At close: May 28, 4:47 PM EDT

$9.81

0.141.45%

After Hours: 4:47 PM EDT

Forte Biosciences (FBRX) Forecast

News Earnings Forte Biosciences (FBRX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Forte Biosciences Stock Price, Quotes and Forecasts | NASDAQ:FBRX | Benzinga

Explore Forte Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FBRX.

Open	-
Close	-
Volume / Avg.	0 / 48.03K
Day Range	- - -
52 Wk Range	4.11 - 28.68
Market Cap	$64.58M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	2.8%
Days to Cover	4.61

Recent News

Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Forte Biosciences (FBRX) Stock Is Trading Lower

Forte Biosciences shares are trading lower by 13.6% Monday afternoon. The company announced plans for the periodic resale of up to 9.5 million common stock shares by selling stockholders.

Henry Khederian

Forte Biosciences Shares Are Soaring Today: What's Going On?

Forte Biosciences Inc. (NASDAQ: FBRX) shares are trading higher Wednesday. The company announced a $53 million private placement to fund the development of its autoimmune-focused drug candidate, FB102. Here's what you need to know.

Vaishali Prayag

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 48.03K
Day Range	- - -
52 Wk Range	4.11 - 28.68
Market Cap	$64.58M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	2.8%
Days to Cover	4.61

About Forte Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials it...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Forte Biosciences (FBRX) stock?

You can purchase shares of Forte Biosciences (NASDAQ:FBRX) through any online brokerage.

View our list of the best stock brokerages

Who are Forte Biosciences (FBRX) competitors?

Other companies in Forte Biosciences’s space includes: Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Zentalis Pharma (NASDAQ:ZNTL), Armata Pharmaceuticals (AMEX:ARMP) and Inovio Pharmaceuticals (NASDAQ:INO).

What is the forecast, or price target, for Forte Biosciences (FBRX) stock?

Forte Biosciences has a consensus price target of $22.58.

What is the current price for Forte Biosciences (FBRX)?

The stock price for Forte Biosciences (NASDAQ: FBRX) is $9.81 last updated May 28, 2025 at 4:47 PM EDT.

Does Forte Biosciences (FBRX) pay a dividend?

There are no upcoming dividends for Forte Biosciences.

When is Forte Biosciences (NASDAQ:FBRX) reporting earnings?

Forte Biosciences’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Forte Biosciences (FBRX) going to split?

There is no upcoming split for Forte Biosciences.

What sector and industry does Forte Biosciences (FBRX) operate in?

Forte Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.